Forecast
Period
|
2026-2030
|
Market
Size (2024)
|
USD
545.15 Million
|
Market
Size (2030)
|
USD
685.46 Million
|
CAGR
(2025-2030)
|
3.85%
|
Fastest
Growing Segment
|
MRI
Systems
|
Largest
Market
|
Marmara
|
Market Overview
Turkey Diagnostics Imaging market was valued at USD 545.15 Million in 2024 and
is expected to reach USD 685.46 Million by 2030 with a CAGR of 3.85%. The Turkey Diagnostic Imaging Market is
undergoing robust growth, propelled by a convergence of demographic shifts,
escalating healthcare demand, and advancements in imaging technology. The
market spans a comprehensive range of modalities, including X-ray, MRI, CT
scanners, ultrasound, and nuclear imaging solutions, catering to diverse
diagnostic needs. The rising focus on early disease detection, coupled with the
increased prevalence of chronic conditions and a rapidly aging population,
positions Turkey as a key player within the regional healthcare landscape.
This
market offers substantial growth prospects, driven by Turkey's evolving
healthcare requirements, technological adoption, and strategic investments in
healthcare infrastructure. As the country addresses the rising burden of chronic
diseases, oncological cases, and the specific demands of an aging demographic,
the diagnostic imaging sector is poised to remain a central pillar of Turkey's
healthcare framework. This dynamic environment presents significant
opportunities for both established industry leaders and emerging players to
capitalize on Turkey's evolving healthcare needs and its commitment to advanced
diagnostic solutions.
Key Market Drivers
Rising Prevalence of Chronic
Diseases
The
rising prevalence of chronic diseases is one of the most influential and
sustained growth drivers for the Turkey Diagnostic Imaging Market. In Turkey,
the healthcare system faces a substantial challenge due to the high incidence
of chronic diseases, which now account for a majority of all-cause mortality. Notably,
chronic kidney disease (CKD) affects approximately 15.7% of the population,
underscoring a critical and growing demand for continuous diagnostic monitoring
and advanced imaging support. Chronic
diseases such as cardiovascular disorders, cancer, diabetes, and chronic
respiratory conditions are on the rise in Turkey, driven by factors such as
sedentary lifestyles, unhealthy diets, smoking, urbanization, and genetic
predisposition. In 2022,
Turkey recorded 240,013 newly diagnosed cancer cases across both genders,
reflecting a significant clinical workload. The age-standardized incidence rate
(ASR) stood at 225 per 100,000 population, indicating a sustained rise in
oncology-related healthcare demand.
These conditions typically require early and accurate diagnosis for effective
treatment planning and disease management. Diagnostic imaging techniques such
as MRI, CT scans, X-rays, and ultrasound play a central role in: Initial
diagnosis, Disease staging, Progress monitoring, Post-treatment assessment. This
leads to repeat and long-term utilization of imaging equipment, thereby
increasing the volume and frequency of diagnostic procedures conducted in
hospitals and imaging centers.
With
chronic diseases becoming more prevalent, the healthcare landscape in Turkey is
gradually shifting from reactive to preventive and personalized care. Imaging
is a key enabler in this transition, offering non-invasive, precise, and
real-time insights into internal pathologies. As medical professionals focus on
risk-based screenings and proactive health management, especially for high-risk
groups, diagnostic imaging is increasingly being used as a routine part of care
protocols particularly for: Cancer screenings (e.g., mammograms, CT lung scans),
Cardiovascular risk assessments (e.g., echocardiography, angiography), Diabetes-related
complications (e.g., retina imaging, foot and kidney assessments). This
sustained clinical reliance on imaging technologies fuels continuous market
expansion. The increasing burden of chronic diseases places significant strain
on the Turkish healthcare system, prompting public health authorities and
private players to invest more heavily in diagnostic infrastructure. Hospitals
are upgrading their imaging departments. Diagnostic centers are expanding into
semi-urban and rural areas. Government programs are promoting wider access to
diagnostic services through state-funded insurance schemes and public-private
partnerships. These systemic changes are increasing installed imaging capacity,
which in turn supports long-term market growth. Many chronic conditions require
multi-modality diagnostics0020where multiple imaging techniques are used
together to provide a comprehensive clinical picture. A cancer patient may
require an ultrasound for lump detection, a CT scan for staging, and an MRI for
soft tissue evaluation. Cardiovascular patients may need X-rays,
echocardiograms, and nuclear imaging. This layered approach leads to higher
imaging volumes per patient, boosting overall utilization rates of imaging
equipment and increasing revenue opportunities for healthcare providers and
imaging equipment suppliers.
Aging Population
The
aging population is a major structural driver contributing to the sustained
expansion of the Turkey Diagnostic Imaging Market. Turkey is experiencing a
notable demographic transformation, with the aging population becoming a
significant factor in shaping healthcare demand. The proportion of individuals
aged 65 and above has grown from 8.8% in 2018 to 10.2% in 2023, signaling an
ongoing shift towards an older population. As individuals age, they become
increasingly vulnerable to a wide range of chronic and degenerative conditions,
including Cardiovascular diseases, Osteoporosis and joint disorders, Neurological
disorders such as Alzheimer’s and Parkinson’s, Various forms of cancer, Pulmonary
and renal dysfunctions. These conditions require frequent and detailed
diagnostic imaging for detection, monitoring, and treatment evaluation.
Modalities such as MRI, CT scans, X-rays, bone densitometry (DEXA), and
ultrasound are commonly used in geriatric care. As a result, a larger elderly
population automatically leads to greater demand for these imaging services. In
Turkey, healthcare service utilization, particularly physician visits, remains
notably high relative to other developed nations. The country has consistently
recorded robust per capita physician visit rates, with figures of 8.6 in 2016,
8.9 in 2017, 9.5 in 2018, and 9.8 in 2019. This trend reflects a strong demand
for healthcare access, driven by a high level of patient engagement with
medical services. Older adults typically have higher rates of healthcare
utilization, both in terms of hospital visits and diagnostic procedures. They
often require: Regular screenings, Follow-up imaging for chronic disease
management, Pre- and post-surgical assessments, Emergency imaging (e.g.,
stroke, fractures, heart attacks). This leads to a higher per capita imaging
rate among the elderly compared to younger demographics, thereby fueling volume
growth in diagnostic imaging centers and hospitals across Turkey.
The
elderly population often requires specialized imaging technologies tailored to
their medical needs. Low-dose CT scans to minimize radiation exposure, Advanced
MRI techniques to detect early neurodegenerative changes, Bone mineral density
tests (DEXA) for osteoporosis, Ultrasound and Doppler imaging for vascular and
abdominal conditions. This need for targeted, safe, and high-resolution imaging
is prompting healthcare facilities to upgrade equipment and adopt new
technologies a trend that drives capital investment and market growth. Turkey’s
healthcare system is gradually evolving to accommodate its aging population. Establishment
of geriatric departments in hospitals, Growth of elder care homes and
specialized clinics, Government initiatives promoting preventive screenings for
the elderly. As geriatric healthcare infrastructure expands, diagnostic imaging
becomes an essential component of care delivery, further increasing the
installed base and utilization of imaging technologies.

Download Free Sample Report
Key Market Challenges
High Capital and Operational
Costs
Diagnostic
imaging technologies such as MRI, CT, PET-CT, and digital X-ray systems require
significant upfront investment. In addition to procurement costs, there are
ongoing operational expenses related to: Maintenance and servicing of high-tech
equipment, Upgrades and calibration, Skilled personnel training and retention, Compliance
with safety and quality regulations.
These
high costs pose a barrier to wider adoption in small- and mid-sized healthcare
facilities, especially in semi-urban and rural areas. Public hospitals often
rely on government budgets or public-private partnerships (PPPs), while private
diagnostic centers may struggle to balance quality with profitability. The long
payback periods and unpredictable patient volumes also limit the willingness of
private investors to enter or expand within the imaging sector. This restricts
market penetration and slows infrastructure development outside major
metropolitan areas.
Uneven Access and Regional
Disparities
Access
to advanced diagnostic imaging remains uneven across Turkey, with a
concentration of modern imaging facilities in urban centers like Istanbul,
Ankara, and Izmir. In contrast, rural and remote regions often face: Shortages
of imaging infrastructure, Limited availability of trained radiologists and
technicians, Delays in image interpretation and reporting.
This
geographic imbalance creates inequitable healthcare delivery and limits the
overall utilization of imaging technologies at the national level. Patients in
underserved areas may face long wait times or be forced to travel to larger
cities for diagnostic procedures, which discourage timely screenings and early
diagnosis. The resulting underutilization of imaging services in certain
regions hinders national market growth and prevents the industry from achieving
scale and efficiency.
Key Market Trends
Strategic Expansion of City
Hospitals (Şehir Hastaneleri) with Integrated Imaging Hubs
A
key structural transformation in Turkey’s healthcare sector is the development
of large-scale, government-backed city hospitals under Public-Private
Partnership (PPP) models. These mega hospitals are designed as centralized,
high-capacity medical ecosystems that include dedicated diagnostic imaging hubs
equipped with advanced imaging suites (MRI, CT, PET-CT, Interventional
Radiology, etc.). Unlike standalone hospitals, these city hospitals offer high
patient throughput, which supports the economic viability of expensive imaging
equipment. Moreover, they function as referral centers for regional healthcare
networks, ensuring a steady and diverse caseload from trauma and cancer to
prenatal diagnostics.
Creates
sustained demand for high-end imaging solutions and service contracts, Encourages
vendor partnerships and long-term leasing models for equipment providers, Sets
the standard for digital integration and imaging informatics, prompting
upgrades in surrounding hospitals. This trend is unique to Turkey's healthcare
policy landscape and is a defining driver for future equipment procurement,
software integration, and managed imaging services.
Surge in Radiology Outsourcing
and Teleradiology Networks
Turkey
is experiencing a critical shortage of qualified radiologists, particularly in
Tier-2 and Tier-3 cities. In response, healthcare providers both public and
private are increasingly adopting radiology outsourcing models, including
teleradiology, where image interpretation is performed remotely by radiologists
located in urban centers or abroad. This is not simply a workforce workaround it
is creating a new service layer in the diagnostic imaging value chain.
Radiology-as-a-service platforms are emerging, combining AI-based pre-screening
tools, Secure PACS (Picture Archiving and Communication Systems), Cloud-based
diagnostic workflows. Expands imaging access to underserved regions without
needing local radiologists. Stimulates demand for interoperable imaging
platforms, cloud PACS, and secure data transfer systems. Opens up B2B revenue
streams for private radiology firms and imaging service providers. This trend
reflects a shift from hardware-driven to service-oriented market dynamics, with
scalable, subscription-based imaging services becoming increasingly common.
Segmental Insights
Type Insights
Based
on the category of Type, the MRI Systems segment emerged as the fastest growing
segment in the Turkey Diagnostics Imaging Market in 2024. Magnetic Resonance
Imaging (MRI) has become the modality of choice for evaluating complex
neurological, orthopedic, and soft tissue conditions — areas where precision
and tissue contrast are critical. Increasing incidence of neurological
disorders such as stroke, multiple sclerosis, and Alzheimer’s disease in
Turkey’s aging population. Surge in sports injuries, arthritis, and spinal
conditions require detailed soft tissue imaging. MRI is also widely used in
pre-surgical planning and post-operative monitoring, especially in orthopedic
and neuro-oncology fields. These clinical trends are pushing both public
hospitals and private diagnostic centers to upgrade or expand their MRI
capabilities, leading to strong segmental growth.
Turkey's
Ministry of Health has made strategic investments in high-end medical imaging
infrastructure as part of its healthcare modernization program, especially
within city hospitals and tertiary referral centers. Deployment of 1.5T and 3T
MRI machines in newly built public hospitals. Public-private partnerships
(PPPs) enabling financing and installation of MRI units across large hospitals.
Favorable procurement policies under the Social Security Institution (SGK)
which support access to advanced diagnostics. This trend is creating
institutional demand for MRI systems, positioning the modality as a standard
diagnostic asset in major healthcare facilities across Turkey. These factors
are expected to drive the growth of this segment.
Application Insights
Based
on the category of Application, the Oncology segment emerged as the dominating
segment in the Turkey Diagnostics Imaging Market in 2024. Cancer is one of the
leading causes of morbidity and mortality in Turkey, with rising prevalence of
lung, breast, colorectal, and prostate cancers. Urban lifestyle changes, aging
demographics, and environmental factors contributing to cancer risk. Government-reported increase in new cancer
diagnoses annually. Early detection campaigns encouraging population-wide
screenings.
This
epidemiological shift has placed oncology imaging at the forefront of clinical
demand, leading to high-volume use of: CT scans and MRIs for tumor localization
and staging, PET-CT scans for metabolic imaging and metastasis detection, Ultrasound
and mammography for breast and reproductive cancers. These procedures are
essential across diagnosis, treatment planning, and ongoing monitoring,
ensuring continuous usage throughout the patient journey.
The
Turkish Ministry of Health actively promotes cancer prevention and early
detection through nationwide screening programs for: Breast cancer
(mammography), Cervical cancer (HPV/Pap smear, ultrasound), Colorectal cancer
(colonoscopy supported by imaging if needed). The deployment of KETEM centers
(Cancer Early Diagnosis, Screening, and Training Centers). Mobile units using
portable imaging equipment for rural and underserved areas. Integration of
imaging in follow-up protocols for patients with positive screening results. These
initiatives have led to a surge in demand for diagnostic imaging in oncology,
especially for modalities used in screening and confirmation phases. The result
is sustained procedural volume and imaging center throughput in both the public
and private sectors.

Download Free Sample Report
Regional Insights
The
Marmara Region, home to Istanbul and several other economic hubs, stands out as
the largest and most influential market in the Turkey Diagnostic Imaging
Market. This dominance is the result of a synergistic mix of demographic
density, economic leadership, healthcare infrastructure maturity, and private
sector investment factors that make the region a central driver of imaging
demand and technological adoption.
The
Marmara Region is the most populous and urbanized region in Turkey, accounting
for over 25% of the national population, with Istanbul alone hosting more than
15 million residents. High patient volumes across urban centers lead to
increased utilization of diagnostic services. Greater prevalence of
lifestyle-related and age-related diseases in dense, urban populations. High
awareness and accessibility to healthcare prompt earlier diagnostic
interventions. This concentration of people and disease burden ensures a steady
and diverse demand for imaging services, ranging from routine radiology to
advanced oncology and cardiology imaging.
The
Marmara Region, particularly Istanbul, is home to the highest concentration of
private hospitals, diagnostic imaging chains, and medical tourism centers in
Turkey. Leading private hospital groups (e.g., Acıbadem, Memorial, Medicana)
are headquartered or heavily invested in Marmara. A competitive healthcare
market encourages constant investment in cutting-edge imaging technologies,
such as AI-integrated MRI and PET-CT scanners. High-income populations and
international patients seek premium imaging services, further fueling demand. This
market-oriented environment supports faster technology adoption cycles, higher
procedural volumes, and a more diversified imaging portfolio, making Marmara
the most commercially attractive region
Recent Developments
- In
December 2024- Memorial Hospitals Group in Turkey has strategically partnered
with Aiforia Technologies Plc to integrate AI-assisted clinical diagnostics
into its pathology services. This collaboration will leverage Aiforia's
regulatory-approved clinical AI solutions to enhance the analysis of tissue
samples, particularly for breast, prostate, and lung cancer patients at Memorial
Pathology. By utilizing Aiforia's advanced AI technology, Memorial Hospitals
Group aims to improve the accuracy and efficiency of its diagnostic processes,
marking a significant step towards the integration of artificial intelligence
in precision oncology diagnostics.
- In
June 2024, Genoks, a prominent Turkish genomics healthcare firm, has entered
into a strategic partnership with Velsera, a global leader in healthcare
technology known for its universal software platform that bridges clinical care
and scientific discovery. This collaboration is focused on advancing cancer
diagnostics and treatment capabilities across Turkey and surrounding regions.
By combining Genoks' expertise in genomics with Velsera's cutting-edge
platform, the partnership aims to enhance personalized cancer care, streamline
diagnostic workflows, and accelerate the development of precision oncology
solutions in the region.
Key Market Players
- Canon
Medical Systems Corporation Turkey
- XERA MEDICAL SYSTEMS & TECHNOLOGY
CO. LTD
- FUJIFILM DIS TICARET AS
- GE HealthCare Technologies Inc
- Siemens Healthineers Hakkında
- Turk Philips Ticaret AS
- SHIMADZU Middle East & Africa
- Toshiba Medical Systems Corporation
("TMSC")
- Inter-Med A.S
- Esaote Biomedica Medical Systems Inc
By
Type
|
By
Mobility
|
By
Source
|
By
Application
|
By
Region
|
- X-Ray
Imaging Solutions
- Ultrasound
Systems
- MRI
Systems
- CT
Scanners
- Nuclear
Imaging Solutions
|
|
|
- Cardiology
- Oncology
- Neurology
- Orthopedics
- Gastroenterology
- Gynecology
- Others
|
- Marmara Region
- Central Anatolia
- Eastern Anatolia Region
- South-Eastern
Anatolia Region
- Aegean
Region
- Mediterranean
Region
- Black
Sea Region
|
Report Scope:
In this report, the Turkey Diagnostics Imaging
Market has been segmented into the following categories, in addition to the
industry trends which have also been detailed below:
- Turkey Diagnostics Imaging Market, By Type:
o X-Ray Imaging Solutions
o Ultrasound Systems
o MRI Systems
o CT Scanners
o Nuclear Imaging Solutions
- Turkey Diagnostics Imaging Market, By Mobility:
o Portable
o Standalone
- Turkey Diagnostics Imaging Market, By Source:
o Domestic
o Import
- Turkey Diagnostics Imaging Market, By Application:
o Cardiology
o Oncology
o Neurology
o Orthopedics
o Gastroenterology
o Gynecology
o Others
- Turkey Diagnostics Imaging Market, By End User:
o Hospitals & Clinics
o Diagnostic Centers
o Ambulatory Care Centers
o Others
- Turkey Diagnostics Imaging Market, By Region:
o Marmara Region
o Central Anatolia
o Eastern Anatolia Region
o South-Eastern Anatolia Region
o Aegean Region
o Mediterranean Region
o Black Sea Region
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Turkey
Diagnostics Imaging Market.
Available Customizations:
Turkey
Diagnostics Imaging market report with the given market data, TechSci
Research offers customizations according to a company's specific needs. The following
customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional
market players (up to five).
Turkey Diagnostics Imaging Market is an
upcoming report to be released soon. If you wish an early delivery of this
report or want to confirm the date of release, please contact us at [email protected]